Scientists have developed a blood test to track the resistance of tumors in real time.
New microarray developed by Oxford Gene Technology is to facilitate understanding of cancer formation and development
CytoSureTM Cancer +SNP array to enable the development of more targeted anti-cancer therapies.
Partnership provides first single blood test for dementia.
Partnership’s research initiatives announced in the field of glycomics to enhance innovation using analytical methods.
Research collaboration focuses on prostate cancer biomarkers.
Günther Laukien (1924–1997) recognized as “one of the great pioneers” in analytical chemistry.
Cedars-Sinai Medical Center and the University of California collaborate to develop enhanced tumor cell technology.
PPD’s cell-based assay laboratory to be extended to enhance service capabilities.
New data system is capable of processing chromatography and MS data under the same software umbrella.
New partnership provides compliant technology to life science organizations.